4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000145
Chairperson & CEO sold 9,500 shares at an average $494.79 ($4,700,505)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-18 | Sale : show line 2 in the form 10b5-1 | −248 | $492.91 | $122,241 | 333,695 | I |
| 2026-09-18 | Sale : show line 3 in the form 10b5-1 | −2,216 | $493.78 | $1,094,209 | 331,479 | I |
| 2026-09-18 | Sale : show line 4 in the form 10b5-1 | −4,269 | $494.70 | $2,111,871 | 327,210 | I |
| 2026-09-18 | Sale : show line 5 in the form 10b5-1 | −2,330 | $495.66 | $1,154,894 | 324,880 | I |
| 2026-09-18 | Sale : show line 6 in the form 10b5-1 | −277 | $496.64 | $137,569 | 324,603 | I |
| 2026-09-18 | Sale : show line 7 in the form 10b5-1 | −160 | $498.25 | $79,720 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $494.79 · $4,700,505 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-18 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option | −9,500 | 404,410 | I |
Loading xslF345X06/primarydocument.xml…